EURO.PSE Euro-Med Laboratories Phils Inc

Healthcare Pharmaceuticals Philippine Stock Exchange
Add to portfolio Ask AI about EURO.PSE
1.24 PHP
Close of Oct 30, 2026
0.8430 1.28
Market cap
PHP 7.73B
P/E
-
P/B
-
ROE
6.4%
Dividend yield
3.19%
Fundamental score
2.0/5

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2025.

Is EURO.PSE undervalued?

Graham number

The Graham number of Euro-Med Laboratories Phils Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Euro-Med Laboratories Phils Inc fundamental analysis

8 of 22 checks passed

ROE 0/2

Low return on equity (6.4%), below 10%.

ROA 0/1

Return on assets (3.5%) is below the industry median (3.8%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Earnings growth cannot be compared with the industry.

Revenue Growth 2/2

Revenue grew 17.3% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (25.1%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 0/1

No interest expense reported.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book is negative or not available.

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield cannot be calculated.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 73.1%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Euro-Med Laboratories Phils Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.